Aryl acylamidase activity exhibited by butyrylcholinesterase is higher in chick than in horse, but much lower than in fetal calf serum.
Several side activities have been attributed to butyrylcholinesterase (BChE), including aryl acylamidase (AAA) activity, which is an amidase-like activity with unknown physiological function splitting the artificial substrate o-nitroacetanilide. For avians, extensive developmental data have pointed to neurogenetic functions of BChE, however, a possible AAA activity of BChE has not been studied. In this study, we first compare the relative levels of AAA exhibited by BChE in whole sera from chick, fetal calves (FCS) and horse. Remarkably, FCS exhibits a 400-fold higher ratio of AAA/BChE than horse and 80-fold higher than chick serum. We then show that an immunoisolated preparation of BChE from chicken serum presents significant activity for AAA. Both in sera and with the purified enzyme, the AAA activity is fully inhibited by anticholinesterase drugs, showing that AAA activity is exclusively conveyed by the BChE molecule. Noticeably, AAA inhibition even occurs at lower drug concentrations than that of BChE activity itself. Moreover, AAA is sensitive to serotonin. These data indicate that (1) AAA is a general feature of serum BChE of vertebrates including avians, (2) AAA is effectively inhibited by cholinergic and serotonergic agents, and (3) AAA may have a developmental role, since it is much pronounced in a serum from fetal animals. Functionally, deamination of neuropeptides, a link between cholinergic and serotonergic neurotransmitter systems, and roles in lipoprotein metabolism could be relevant.
Weitnauer
E
E
Department of Developmental Biology and Neurogenetics, Institute for Zoology, Darmstadt University of Technology, Darmstadt, Germany.
Robitzki
A
A
Layer
P G
PG
D000109:Acetylcholine / Q000494:pharmacology; D000581:Amidohydrolases / Q000097:blood*; D000818:Animals; D002091:Butyrylcholinesterase / Q000097:blood* / Q000302:isolation & purification; D002417:Cattle; D002645:Chickens; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D005312:Fetal Blood; D005333:Fetus; D006736:Horses; D007700:Kinetics; D010830:Physostigmine / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D013045:Species Specificity; D013770:Tetraisopropylpyrophosphamide / Q000494:pharmacology
D002800:Cholinesterase Inhibitors; D013770:Tetraisopropylpyrophosphamide; D010830:Physostigmine; D002091:Butyrylcholinesterase; D000581:Amidohydrolases; C019732:aryl acylamidase; D011342:Procainamide; D000109:Acetylcholine